Plain-English translation of NCT06764485 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called to see if it can help men with advanced prostate cancer that no longer responds to standard hormone treatments. You would receive either this medication or one of three standard treatments ( chemotherapy, , or ), depending on which group you're randomly assigned to. The goal is to learn whether the medication can slow cancer growth better than the treatments doctors typically use.
Once prostate cancer stops responding to initial hormone therapies, treatment options become limited and the disease tends to progress quickly. This trial is being conducted to see whether this medication can offer men a more effective option to control their cancer and extend their survival.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to receive either the new medication or one of the standard treatments. The trial has two parts: in Part 1, researchers test different doses of the medication to find the best one, and in Part 2, they compare that dose to standard treatments. Throughout the trial, you would have regular visits for blood tests, imaging scans to check if your cancer is growing, and check-ups to monitor how you're doing on the treatment.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
United States